Creative Biolabs Launches Antibody Tools for Neuroscience Research Targeting Key Disease Mechanisms

Creative Biolabs has developed a comprehensive suite of antibody tools targeting key neuroscience proteins that play critical roles in neurodegenerative diseases, movement disorders, and muscle function research. The nervous system requires integration of molecular biology, structural biology, and clinical medicine approaches due to its complexity, particularly as the global burden of neurological conditions continues to increase. Researchers are actively seeking new molecular mechanisms and treatment options for these challenging conditions.

The company has produced anti-GRID2 antibody products, including Rabbit Anti-GRID2 Recombinant Antibody and Mouse Anti-GRID2 Recombinant Antibody, which are available to the scientific community. Research has demonstrated that mutations of the GRID2 gene can lead to cerebellar ataxia and learning deficits, showing that GRID2 plays a dominant role in motor coordination and synaptic transmission. These products are applicable in ELISA, flow cytometry, Western blotting, and immunohistochemistry, allowing researchers to accurately study spatial characteristics and dynamic regulation of synaptic proteins. In neurological disease models, abnormal GRID2 expression reflects not only molecular mechanisms of neural circuit imbalance but also provides a rationale for the potential of targeted interventions.

For neurotransmitter metabolism research, Creative Biolabs offers Mouse Anti-Tyrosine Hydroxylase Recombinant Antibody targeting tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. TH catalyzes the conversion of L-tyrosine to L-DOPA, which subsequently produces dopamine, norepinephrine, and epinephrine. This antibody is optimized for Western blot and immunohistochemistry applications, helping researchers sensitively capture molecular changes along neurotransmitter synthesis pathways. In Parkinson's disease research, changes in TH levels reflect the functional state of dopaminergic neurons, making TH an important marker for drug discovery and disease diagnosis.

The company also provides ACTN3-related products, including Mouse Anti-ACTN3 Recombinant Antibody and Rabbit Anti-ACTN3 Recombinant Antibody with high specificity and cross-species applications. The ACTN3 gene encodes α-actinin-3, a critical protein for maintaining the structural integrity and explosive power of fast-twitch muscle fibers. These tools support studies in sports genetics, muscle disorders, and personalized training research, addressing the growing interest in genetic regulation within the motor system. The availability of these specialized antibody tools represents a significant advancement for neuroscience research, enabling more precise investigation of molecular mechanisms underlying various neurological and muscular conditions.